Company: CRAC
Filing Date: 2025-09-04
Form Type: S-1/A
Source: 0001213900-25-084243
Chunk: 143

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-09-04
Form: S-1/A
Chunk 143
---
 | ) |     |           |  (4,201,375 | ) |     |                |  (7,266,750 | ) |     |           |  (8,402,750 | ) |     |                |  (10,900,125 | ) |     |           |  (12,604,125 | ) |     |             |  (14,533,500 | ) |     |           |  (16,805,500 | ) |
| Total                                                                                                       |     |                |  20,165,625 |   |     |           |  23,118,750 |   |     |                |  16,532,250 |   |     |           |  18,917,375 |   |     |                |  12,898,875 |   |     |           |  14,716,000 |   |     |                |    9,265,500 |   |     |           |   10,514,625 |   |     |             |    5,632,125 |   |     |           |    6,313,250 |   |

____________ (1) Expenses applied against gross proceeds include offering expenses of approximately $580,000 and underwriting commissions of $1,500,000 (excluding deferred underwriting commissions) in the aggregate. See “Use of Proceeds.”

93

(2) Upon the consummation of our initial business combination, $300,000 will be payable to Polaris for deferred underwriting commissions. See also “Underwriting” for a description of compensation and other items of value payable to the underwriter. (3) Represents the value of 45 -dayover -allotmentoption from the date of this offering granted to the underwriter to purchase an aggregate of up to 2,250,000 additional units at the initial public offering price less the underwriting commissions. The over -allotmentoption is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480. (4)If we seek shareholder approval of our initial business combination and we do not conduct repurchases in connection with our initial business combination pursuant to the tender offer rules, our initial shareholders, directors, officers or any of their respective affiliates may purchase public shares in privately negotiated transactions or in the open market either prior to or following the completion of our initial business